Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation

Pediatric Transplantation

Volumn 1, Issue 2, 1997, Pages 124-129

  Ringden O ^a   Ekelof Andstrom E ^a   Remberger, M ^a   Dahllof G ^a   Svahn, B M ^a   Tollemar, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adverse effects; Ambisome; Amphotericin B; Antimycotic chemotherapy; Bone marrow transplantation; Efficacy; Liposomal formulation; Liver transplantation; Opportunistic mycosis; Safety

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; LIPOSOME;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HUMAN; INFANT; MALE; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; AMPHOTERICIN B; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTICS, ANTIFUNGAL; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LIPOSOMES; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031261166     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. DUPONT B. Clinical manifestations and management of candidosis in the compromised patient. In: WARNOCK DW, RICHARDSON MD, eds. Fungal infection in the compromised patient. Chichester: John Wiley & Sons, 1991: p. 56-85.
2. DENNING DW. Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. J Antimicrob Chemother 1991: 28(suppl B): 17-25.
3. TOLLEMAR J, RINGDÉN O, BOSTRÖM L, NILSSON B, SUNDBERG B. Variables predicting deep fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 1989: 4: 635-641.
4. GOODRICH JM, REED EC, MORI M, FISHER LD, SKERRTEE S, DANDLIKER PS, et al. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis 1991: 164: 731-740.
5. LOPEZ-BERESTEIN G, FAINSTEIN V, HOPPER R, METHA K, SULLIVAN M, et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer. A preliminary study. J Infect Dis 1985: 151: 704-710.
6. LOPEZ-BERESTEIN G, BODEY GP, FRANKEL LS, METHA K. Treatment of hepatosplenic candidiasis with liposomal amphotericin B. J Clin Oncol 1987: 5: 310-317.
7. TOLLEMAR J, RINGDÉN O, TYDÉN G. Liposomal amphotericin-B (AmBisome) treatment in solid organ and bone marrow transplant recipients. Efficacy and safety evaluation. Clin Transplant 1990: 4: 167-175.
8. MEUNIER F, PRENTICE HG, RINGDÉN O. Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. J Antimicrob Chemother 1991: 28 (Suppl B): 83-91.
9. RINGDÉN O, MEUNIER F, TOLLEMAR J, RICCI P, TURA S, KUSE ER, et al. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother 1991: 28(Suppl. B): 73-82.
10. SHULMAN H, STRIKER G, DEEG HJ, KENNEDY M, STORB R, THOMAS ED. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. N EngI J Med 1981: 305: 1392-1395.
11. ZOUBEK A, EMMINGER W, EMMINGER-SCHMIDMEIER W, PETERS C, PRACHER E, GROIS N, GADNER H. Conventional vs. liposomal amphotericin B in immunosuppressed children. Pediatric Hematol Oncol 1992: 9: 187-190.
12. LACKNER H, SCHWINGER W, URBAN C, MÜLLER W, RITSCHL E, REITERER F, et al. Liposomal amphotericin B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics 1992: 89: 1259-1261.
13. RINGDÉN O, TOLLEMAR J. Liposomal amphotericin B (AmBisome®) treatment of invasive fungal infections in immunocompromised children. Mycoses 1993: 36: 187-192.
14. EMMINGER W, GRANINGER W, EMMINGER-SCHMIDMEIER W, ZOUBEK A, PILLWEIN K, SUSANI M, et al. Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer. Ann Hematol 1994: 68: 27-31.
15. DORNBUSCH HJ, URBAN CE, PINTER H, GINTER G, FOTTER R, BECKER H, MIORINI T, et al. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (Am-Bisome), granulocyte colony-stimulating factor, and surgery: Report of five cases. Pediatr Hematol Oncol 1995: 12: 577-586.